Fluocinolone intravitreal implant (Iluvien) for macular edema secondary to immune recovery uveitis in patient with acute myeloid leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Fluocinolone intravitreal implant (Iluvien) for macular edema secondary to immune recovery uveitis in patient with acute myeloid leukemia ; volume:14 ; number:1 ; day:3 ; month:5 ; year:2024 ; pages:1-5 ; date:12.2024
Journal of ophthalmic inflammation and infection ; 14, Heft 1 (3.5.2024), 1-5, 12.2024
- Creator
-
Cachero Rodríguez, JM
Artaraz, J.
Imaz, Nora
Fonollosa, A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12348-024-00397-y
- URN
-
urn:nbn:de:101:1-2407142109335.207724470767
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cachero Rodríguez, JM
- Artaraz, J.
- Imaz, Nora
- Fonollosa, A.
- SpringerLink (Online service)
Other Objects (12)
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
Changes in Macular Perfusion After ILUVIEN® Intravitreal Implant for Diabetic Macular Edema: An OCTA Study
Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
Efficacy of intravitreal dexamethasone implant used as monotherapy for the treatment of macular edema in non-infectious uveitis: a retrospective analysis
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
Mid-term safety and effectiveness of macular peeling one month after intravitreal dexamethasone implant for tractional diabetic macular edema
Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema
Retinal Morpho-Functional Changes Following 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Chronic Diabetic Macular Edema
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
Changes in Macular Perfusion After ILUVIEN® Intravitreal Implant for Diabetic Macular Edema: An OCTA Study
Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
Efficacy of intravitreal dexamethasone implant used as monotherapy for the treatment of macular edema in non-infectious uveitis: a retrospective analysis
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
Mid-term safety and effectiveness of macular peeling one month after intravitreal dexamethasone implant for tractional diabetic macular edema
Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema
Retinal Morpho-Functional Changes Following 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Chronic Diabetic Macular Edema
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
Changes in Macular Perfusion After ILUVIEN® Intravitreal Implant for Diabetic Macular Edema: An OCTA Study
Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
Efficacy of intravitreal dexamethasone implant used as monotherapy for the treatment of macular edema in non-infectious uveitis: a retrospective analysis
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
Mid-term safety and effectiveness of macular peeling one month after intravitreal dexamethasone implant for tractional diabetic macular edema
Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema